CWP
AMED

Concord Wealth Partners’s Amedisys AMED Stock Holding History

Concord Wealth Partners’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11
Closed -$1K – 196
2022
Q2 		$1K Hold
11
– – ﹤0.01% 1096
2022
Q1 		$2K Hold
11
– – ﹤0.01% 1061
2021
Q4 		$2K Hold
11
– – ﹤0.01% 1096
2021
Q3 		$2K Hold
11
– – ﹤0.01% 729
2021
Q2 		$3K Hold
11
– – ﹤0.01% 800
2021
Q1 		$3K Hold
11
– – ﹤0.01% 743
2020
Q4 		$3K Buy
+11
New +$2.82K ﹤0.01% 456

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Concord Wealth Partners's AMED Position: Q3 2022 in Review

Concord Wealth Partners sold out of Amedisys (AMED) in Q3 2022, closing a stake of 11 shares — an estimated $1K sold.

Concord Wealth Partners first reported a position in AMED in Q4 2020 and held it in 7 quarters. The position peaked at $3K in Q2 2021. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2022.

  • Concord Wealth Partners reported no remaining Amedisys position as of Q3 2022 after selling out during the quarter.
  • Concord Wealth Partners sold 11 Amedisys shares in Q3 2022, an estimated $1K.
  • Concord Wealth Partners first reported a position in Amedisys in Q4 2020 and held it in 7 quarters.
  • Concord Wealth Partners's Amedisys position peaked at $3K in Q2 2021.
  • 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2022.

Based on Concord Wealth Partners's 13F filing for Q3 2022, filed 10 Nov 2022.